Feature PaxMedica Stock Rises As Traders Look Forward to Clinical Trial ResultsBy James WilliamFebruary 29, 2024 PaxMedica p.s. has risen nearby the general pardon of clinical trial results. The investigation showed unconditional effects of low-dose suramin…